Risk of TB during biologic therapy of rheumatic diseases
What is the actual risk of tuberculosis during biologic therapy of rheumatic diseases? Which class of drugs carries the highest risk of TB?
What is the actual risk of tuberculosis during biologic therapy of rheumatic diseases? Which class of drugs carries the highest risk of TB?
When should we start pharmacological treatment of osteoporosis?
What is the currently recommended treatment of Behçet disease?
What is key in the differential diagnosis of Behçet disease?
The majority of patients with rheumatic diseases should be diagnosed and treated within several weeks of symptom onset. What rheumatologic emergencies warrant immediate action?
Are topical nonsteroidal anti-inflammatory drugs effective in the treatment of gout?
Is Behçet disease uncommon or rather underdiagnosed? When should it be suspected?
What are the most common errors in the treatment of gout?
Which patients require a lifelong urate-lowering treatment following the first acute gout attack, and in which patients this is not necessary?